News Sentiment

B1MR34 sentiment intelligence

BioMarin Pharmaceutical Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report RSS feed
Weighted score 58 Balanced news tone 13 relevant articles
Exchange SAO Brazil
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 142.02 Week of 10 Jul 2026
Weighted tone 58/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

70/100 classification confidence.

Company focus 13

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend inactive

+0.0% over one week, +0.0% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

H.C. Wainwright reiterates BioMarin stock rating at Neutral

Market Reaction

Balanced read

54/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 70/100 classification
One-week reaction 0.0% Price digesting
Trend fit Trend inactive 0.0% over four weeks
Fair value -24.9% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 6
Neutral 7
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 13
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
PR Newswire 5
Investing.com 4
Investing.com Nigeria 1
Seeking Alpha 1
timothysykes.com 1
StockInvest.us 1

Event Lens

What the news is about

Classified themes
Market update 4
Earnings 4
Analyst action 2
Deals and strategy 2
Guidance 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-13 of 13